Agranulocytosis during clozapine therapy

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 26, Issue 3, 2002, Pages 603-607

  Gaszner, Péter ^a   Makkos, Zoltán ^a   Kosza, Piroska ^a  

^a NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

Author keywords

Agranulocytosis; Clozapine; Granulocytopenia

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BENZODIAZEPINE; CEFOTAXIME; CLOZAPINE; CORTICOSTEROID; DIAZEPAM; FLUCONAZOLE; HALOPERIDOL; IMIPENEM; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TOBRAMYCIN; VITAMIN;

ADULT; AGED; AGRANULOCYTOSIS; ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DELIRIUM; DISEASE COURSE; DRUG BLOOD LEVEL; FEMALE; GRANULOCYTOPENIA; GROUP THERAPY; HEMATOPOIESIS; HUMAN; LEUKOCYTE TRANSFUSION; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; PARANOID SCHIZOPHRENIA; SALIVATION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TREATMENT OUTCOME; XEROSTOMIA;

ADULT; AGRANULOCYTOSIS; CLOZAPINE; FEMALE; HUMANS; MALE; SCHIZOPHRENIA;

EID: 0036197151     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(01)00256-1     Document Type: Article

References (23)

1. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland
2. Clozapine: A hypothesised mechanism for its unique clinical profile
3. Drug-induced agranulocytosis: Review of possible mechanism, and prospect for clozapine studies
4. General pharmacology of clozapine
5. Side effects of clozapine
6. Clozapine in treatment of schizophrenia
7. Agranulocytosis and significant leucopenia with neuroleptic drugs: Results from the AMÜP program
8. Clinical experience with clozapine in Germany
9. Clozapine and the treatment of schizophrenia
10. Leponex-associated granulocytopenia: A review of the situation
11. Clozapine associated agranulocytosis: Risk and aetiology
12. Effects of clozapine on cognitive function in schizophrenia
13. Clozapine: Guidelines for clinical management
14. Dimensions of outcome with clozapine
15. Treatment-resistant schizophrenia - The role of clozapine
16. Clozapine: New research on efficacy and mechanism of action
17. Recent advances in the pharmacotherapy of schizophrenia
18. Clinical management of clozapine patients in relation to efficacy and side-effects
19. Experiences during clozapine treatment with consideration of akathisia
20. Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF). Remission despite continuos treatment with clozapine
21. Is the agranulocytosis a problem in clozapine therapy?
22. Use of granulocyte colony-stimulating factor (filgrastim) in the treatment of non-cytotoxic drug-induced agranulocytosis
23. Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: Possible role in agranulocytosis